Skip to main content

Advertisement

Log in

Pachychoroid spectrum disease and choriocapillary flow analysis in patients with Cushing disease: an optical coherence tomography angiography study

  • Retinal Disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To investigate the presence of pachychoroid spectrum disease (PSD) in patients with Cushing disease (CD) and to evaluate subfoveal choroidal thickness (SFCT) and choriocapillary flow using spectral domain OCT (SD-OCT) with the enhanced depth imaging (EDI) and optical coherence tomography angiography (OCT-A).

Methods

Thirty-two patients with CD and 32 age- and sex-matched healthy volunteers were enrolled in this observational study. All participants had a complete ophthalmic examination including SD-OCT with EDI and OCT-A, and were subjected to the Perceived Stress Scale test (PSS). All patients with CD had hormone test including 24-h urinary-free cortisol (UFC) and plasma adrenocorticotropic hormone (ACTH). We compared SFCT and choriocapillary vessel density (CVD) between the two groups and evaluated the presence of PSD. We investigated the association of hormone level, SFTC, CVD with the presence of CD; the association between the hormone level, SFTC, CVD, the CD disease activity, and duration with the presence of PSD in CD patients; and the association between SFTC and CVD with the hormone level, the CD disease activity, and duration in CD patients.

Results

Higher values of SFCT and CVD were associated with CD (β: 0.028, 95% CI: 0.014; 0.041; β: 0.912, 95%CI: 0.205; 1.62, respectively). Twelve patients with CD (37.5%) reported a PSD in at least one eye, whereas no subject was found in control group (p < 0.001); in particular, 11 CD patients (34%) presented pachychoroid pigment epitheliopathy (PPE) and 1 CD patient (3%) presented polypoidal choroidal vasculopathy/aneurysmal type 1 neovascularization (PCV/AT1). In patients with CD, a significant positive association between SFCT and PSD was found (β: 0.010, 95% CI 0.001; 0.019).

Conclusion

A chronic state of hypercortisolism may have direct implications on the choroid. Patients with CD had higher SFCT values and a significant change in the choriocapillary flow compared to healthy controls. Moreover, PSD was observed only in CD patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Warrow DJ, Hoang QV, Freund KB (2013) Pachychoroid pigment epitheliopathy. Retina 33(8):1659–1672

    Article  PubMed  Google Scholar 

  2. Cheung CMG, Lee WK, Koizumi H et al (2019) Pachychoroid disease. Eye 33(1):14–33

    Article  PubMed  Google Scholar 

  3. Bin WW, Xu L, Jonas JB et al (2013) Subfoveal choroidal thickness: the Beijing eye study. Ophthalmology 120(1):175–180

    Article  Google Scholar 

  4. Mrejen S, Spaide RF (2013) Optical coherence tomography: imaging of the choroid and beyond. Surv Ophthalmol 58(5):387–429

    Article  PubMed  Google Scholar 

  5. Haimovici R, Rumelt S, Melby J (2003) Endocrine abnormalities in patients with central serous chorioretinopathy. Ophthalmology 110(4):698–703

    Article  PubMed  Google Scholar 

  6. Garg SP, Dada T, Talwar D, Biswas NR (1997) Endogenous cortisol profile in patients with central serous chorioretinopathy. Br J Ophthalmol 81(11):962–964. https://doi.org/10.1136/bjo.81.11.962

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Bouzas EA, Karadimas P, Pournaras CJ (2002) Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 47(5):431–448

    Article  PubMed  Google Scholar 

  8. Zhao M, Célérier I, Bousquet E et al (2012) Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy. J Clin Invest 122(7):2672–2679

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Bousquet E, Beydoun T, Zhao M et al (2013) Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study. Retina 33(10):2096–2102

    Article  CAS  PubMed  Google Scholar 

  10. Daruich A, Matet A, Dirani A et al (2015) Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res 48:82–118

    Article  CAS  PubMed  Google Scholar 

  11. Abalem MF, Machado MC, Veloso Dos Santos HN et al (2016) Choroidal and retinal abnormalities by optical coherence tomography in endogenous Cushing’s syndrome. Front Endocrinol 7:154

    Article  Google Scholar 

  12. Karaca C, Karaca Z, Kahraman N et al (2017) Is there a role of acth in increased choroidal thickness in cushing syndrome? Retina 37(3):536–543

    Article  CAS  PubMed  Google Scholar 

  13. Wang E, Chen S, Yang H et al (2019) Choroidal thickening and pachychoroid in cushing syndrome: correlation with endogenous cortisol level. Retina 39(2):408–414

    Article  CAS  PubMed  Google Scholar 

  14. Eymard P, Gerardy M, Bouys L et al (2021) Choroidal imaging in patients with Cushing syndrome. Acta Ophthalmol 99(5):533–537

    Article  PubMed  Google Scholar 

  15. Cushing H (1994) The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism) 1932. Obes Res 2(5):486–508

    Article  CAS  PubMed  Google Scholar 

  16. Öner A, Deliktas G, Arda H et al (2014) Diurnal variation of central choroidal thickness in healthy Turkish subjects measured by spectral-domain optical coherence tomography. Retina-Vitreus 22(3):204–208

    Google Scholar 

  17. Nieman LK, Biller BMK, Findling JW et al (2008) The diagnosis of Cushing’s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93(5):1526–1540

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Vallejo MA, Vallejo-Slocker L, Fernández-Abascal EG, Mañanes G (2018) Determining factors for stress perception assessed with the Perceived Stress Scale (PSS-4) in Spanish and other European samples. Front Psychol 9:37

    Article  PubMed  PubMed Central  Google Scholar 

  19. Bouzas EA, Scott MH, Mastorakos G et al (1993) Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol 111(9):1229–1233

    Article  CAS  PubMed  Google Scholar 

  20. Giovansili I, Belange G, Affortit A (2013) Cushing disease revealed by bilateral atypical central serous chorioretinopathy: case report. Endocr Pract 19(5):e129-33

    Article  PubMed  Google Scholar 

  21. Yannuzzi LA (2012) Type A behavior and central serous chorioretinopathy. Retina 32(Suppl 1):709

    Article  PubMed  Google Scholar 

  22. Williams RB, Lane JD, Kuhn CM et al (1982) Type A behavior and elevated physiological and neuroendocrine responses to cognitive tasks. Science (80- ) 218(4571):483–485

    Article  Google Scholar 

  23. Siedlecki J, Schworm B, Priglinger SG (2019) The pachychoroid disease spectrum-and the need for a uniform classification system. Ophthalmol Retin 3(12):1013–1015

    Article  Google Scholar 

  24. Dansingani KK, Balaratnasingam C, Naysan J, Freund KB (2016) En face imaging of pachychoroid spectrum disorders with swept-source optical coherence tomography. Retina 36(3):499–516

    Article  PubMed  Google Scholar 

  25. Dansingani KK, Balaratnasingam C, Klufas MA et al (2015) Optical coherence tomography angiography of shallow irregular pigment epithelial detachments in pachychoroid spectrum disease. Am J Ophthalmol 160(6):1243-1254.e2

    Article  PubMed  Google Scholar 

  26. Gal-Or O, Dansingani KK, Sebrow D et al (2018) Inner choroidal flow signal attenuation in pachychoroid disease: Optical coherence tomography angiography. Retina 38(10):1984–1992

    Article  PubMed  Google Scholar 

  27. Baek J, Kook L, Lee WK (2019) Choriocapillaris flow impairments in association with pachyvessel in early stages of pachychoroid. Sci Rep 9(1):5565

    Article  PubMed  PubMed Central  Google Scholar 

  28. Teussink MM, Breukink MB, Van Grinsven MJJP et al (2015) Oct angiography compared to fluorescein and indocyanine green angiography in chronic central serous chorioretinopathy. Investig Ophthalmol Vis Sci 56(9):5229–5237

    Article  CAS  Google Scholar 

  29. Akkaya S (2018) Spectrum of pachychoroid diseases. Int Ophthalmol 38(5):2239–2246

    Article  PubMed  Google Scholar 

  30. Demirel S, Değirmenci MFK, Batıoğlu F, Özmert E (2021) Evaluation of the choroidal features in pachychoroid spectrum diseases by optical coherence tomography and optical coherence tomography angiography. Eur J Ophthalmol 31(1):184–193

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Nicola Vito Lassandro was involved in the study conception and design. Material preparation, data collection, and analysis were performed by Nicola Vito Lassandro, Michele Nicolai, Luca Cantini, Alessandro Franceschi, Rosaria Gesuita, and Andrea Faragalli. The first draft of the manuscript was written by Nicola Vito Lassandro and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Alessandro Franceschi.

Ethics declarations

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study protocol was approved by the Ospedali Riuniti of Ancona Local Scientific committee.

Consent to participate

Informed consent was obtained from all individual participants included in the study.

Consent to publish

Patients signed informed consent regarding publishing their data and photographs.

Conflict of interest

The authors declare no competing interests.

Disclaimer

The principal investigator, Dr. Lassandro Nicola Vito had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the analysis.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lassandro, N.V., Nicolai, M., Arnaldi, G. et al. Pachychoroid spectrum disease and choriocapillary flow analysis in patients with Cushing disease: an optical coherence tomography angiography study. Graefes Arch Clin Exp Ophthalmol 260, 1535–1542 (2022). https://doi.org/10.1007/s00417-021-05524-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-021-05524-2

Keywords

Navigation